Navigation Links
American Chemical Society's Weekly PressPac -- Aug. 13, 2008
Date:8/19/2008

EMBARGOED FOR RELEASE: Sunday, Aug. 17, 1:30 p.m., Eastern Time

Chemists are reporting a major advance toward developing a safer, fully-synthetic version of heparin, the widely used blood thinner now produced from pig intestines. The U. S. Food and Drug Administration last spring linked contaminated batches of the animal-based product, imported from China, to more than 80 deaths and hundreds of allergic reactions among patients exposed to the drug for kidney dialysis and other conditions.

The purer, non-animal version could improve the drug's safety and bolster regulatory control of its manufacture, the researchers say. Scientists expect demand for heparin, which prevents blood clots, to increase in the future due to rising rates of diabetes, heart disease, and other health complications linked to sedentary lifestyles. Global heparin sales total about $4 billion annually.

"With the problems associated with contaminated heparin produced from pig tissues in China, a non-animal source of this essential drug is gaining importance," says study co-author Robert J. Linhardt. "A safer version of the drug could result in less adverse effects and fewer deaths."

Linhardt points out that processing of pig intestines to extract the raw materials is often done in small, family-run workshops in China, which supplies about 70 percent of the world's heparin. Those mom-and-pop shops often fall outside the normal supervision and regulatory control standard in the pharmaceutical industry. The lack of oversight increases the risks of heparin contamination or adulteration with harmful chemicals, viruses, or other agents, he says. MTS

ARTICLE #2 EMBARGOED FOR RELEASE: Sunday, Aug. 17, 1:30 p.m., Eastern Time

For full-text of press release:
http://oasys.acs.org/output/process_last_run/acs/236nm/-acs-236nm-newsservice-web
'/>"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert  

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 6, 2008
2. Study helps pinpoint genetic variations in European Americans
3. Pictometry and First American Combine Accurate Parcel Addressing With 3-D Like Intelligent Images(TM)
4. American Chemical Societys Weekly PressPac -- July 30, 2008
5. Highlights from the August 2008 Journal of the American Dietetic Association
6. Study suggests 86 percent of Americans could be overweight or obese by 2030
7. American Chemical Societys Weekly PressPac -- July 23, 2008
8. Tips from the Journals of the American Society for Microbiology
9. American Chemical Societys Weekly PressPac -- July 16, 2008
10. Genetic variant increases triglyceride levels in Asian-Americans
11. American Society for Microbiology honors Victor de Lorenzo
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
American Chemical Society's Weekly PressPac -- Aug. 13, 2008
(Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
(Date:3/31/2015)... March 31, 2015  Elephant Talk Communications Corp. (NYSE ... provider of Software Defined Network Architecture (ET Software DNA® ... revenue of approximately $20.4 million for the year ended ... million for the year ended December 31, 2013. ... Company had completed its multi-year transition away from its ...
(Date:3/24/2015)... and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ) has announced ... 2015-2019" report to their offering. The ... at a CAGR of 23.5 percent over the period ... and the growth prospects of the Global Iris Recognition ... size, the report considers the revenue generated from sales ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... Researchers at the University of Gothenburg, Sweden, have developed ... them to controlled environmental changes. The unique method, where ... in a microscopic channel system, allows the researchers to ... a constantly changing environment. Studies on how cells ...
... group of vertebrates sometimes assist a more dominant pair ... this has been shown to occur among subordinate female ... PLoS ONE , Dik Heg and colleagues at the ... suggest that rather than engaging in an act of ...
... available in German . , For modern ... is important to generate materials with characteristics that closely emulate ... of traits that are very hard to recreate in synthetic ... of Australian and Korean researchers led by Geoffrey M. Spinks ...
Cached Biology News:Using high-precision laser tweezers to juggle cells 2The importance of being helpful -- Cooperative cichlids boost their own reproductive success 2Progress toward artificial tissue? 2
(Date:4/17/2015)... Madison, WI (PRWEB) April 17, 2015 ... provide sales and marketing support for the powerful ... at the Chemical Genomics Center at the Lankenau ... LCGC’s mission is to measurably improve successful ... to HTS, by offering rare, drug-like libraries available ...
(Date:4/16/2015)... CAMBRIDGE, Mass. (PRWEB) April 16, 2015 ... of smart data solutions driven by Semantic Web ... provider of specialist information and services for the ... today announced that its joint solution ‘Smart Data ... named a finalist for the 2015 Bio-IT ‘Best ...
(Date:4/16/2015)... Irvine, CA (PRWEB) April 16, 2015 ... in the Buzz of BIO Contest for ... Industry Organization (BIO), the 2015 BIO International Convention will ... in Philadelphia, Pennsylvania. During the Buzz of BIO contest, ... like to see present at the conference. The community ...
(Date:4/16/2015)... According to the 2014 Liberty Mutual ... was ranked first among the leading causes of ... pushing, pulling, holding, carrying, or throwing and cost ... Round Company takes statistics like this very seriously. ... develop and design equipment that prevents these injuries ...
Breaking Biology Technology:BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2
... 2011 Avantra® Biosciences, a leading innovator in ... Avantra,s new service allows researchers to cost effectively ... assays developed on Avantra,s proven QPDx™ BioChip platform. ... multiplex protein assays using catalog or custom reagents. ...
... EntreMed, Inc. (Nasdaq: ENMD ), a ... cancer today announced the presentation of clinical data for ... cancer patients.   The data were presented by the ... medical director of gynecologic oncology at Dana-Farber Cancer Institute ...
... biopharmaceutical product launches have produced both noteworthy failures and ... a continually evolving launch landscape, organizations are rethinking the ... launch environment. In a new wide-ranging ... failure points facing new product launches, Best Practices, LLC ...
Cached Biology Technology:EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 2EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 3EntreMed's ENMD-2076 Demonstrates Clinical Activity in Recurrent, Platinum-Resistant Ovarian Cancer Patients 4Creating a Road Map for Successful Cardiovascular New Product Launch 2
Mouse Endoglin/CD105 Fluorescein MAb (Clone 209701)...
... is an inhibitor of ... concentration of inhibitor required ... must be determined empirically ... micromolar inhibitor is sufficient ...
...
SNARE associated protein snapin, clone MGC:2717...
Biology Products: